BK-2A78

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBK-2A78
Drug Alias NameBK-2A78
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin B2 receptor agonists
TargetsBradykinin B2 receptor
Therapy Area/IndicationsOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A